I'm now keeping an eye on: The SmPC for Cosentyx 300 mg solution for injection in pre-filled syringe

🏭Novartis Pharmaceuticals UK Ltd

💊💉 #secukinumab.

I will let you know if it changes.

🌐 https://www.medicines.org.uk/emc/product/11972/smpc

I'm now keeping an eye on: The SmPC for Cosentyx 150 mg solution for injection in pre-filled pen

🏭Novartis Pharmaceuticals UK Ltd

💊💉 #secukinumab.

I will let you know if it changes.

🌐 https://www.medicines.org.uk/emc/product/3669/smpc

I'm now keeping an eye on: The SmPC for Cosentyx 300 mg solution for injection in pre-filled pen

🏭Novartis Pharmaceuticals UK Ltd

💊💉 #secukinumab.

I will let you know if it changes.

🌐 https://www.medicines.org.uk/emc/product/11973/smpc

I'm now keeping an eye on: The SmPC for Cosentyx 150 mg solution for injection in pre-filled syringe

🏭Novartis Pharmaceuticals UK Ltd

💊💉 #secukinumab.

I will let you know if it changes.

🌐 https://www.medicines.org.uk/emc/product/8119/smpc

I'm now keeping an eye on: The SmPC for Cosentyx 75mg solution for injection in pre-filled syringe

🏭Novartis Pharmaceuticals UK Ltd

💊💉 #secukinumab.

I will let you know if it changes.

🌐 https://www.medicines.org.uk/emc/product/12953/smpc

Secukinumab blocks IL-17 and some evidence of efficacy in hidradenitis suppurativa in 2x RCT.

Interesting in so much this is clearly an inflammatory disease in which there is also undoubtedly an infective component.

These studies, along with efficacy of TNF blockade indicates hyperinflammation the main issue.

#immunology #inflammation #hidradenitis #IL17 #secukinumab #RCT #trial #hyperinflammation

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(23)00022-3/fulltext?dgcid=raven_jbs_aip_email